Barr Laboratories

Barr Laboratories, Inc. is a specialty pharmaceutical company engaged in developing, manufacturing and marketing generic and proprietary pharmaceuticals. A research-intensive pharmaceutical company, Barr is listed on the New York Stock Exchange (NYSE-BRL). With fiscal 2003 revenues of $903 million, the Company currently manufactures and distributes more than 100 pharmaceutical products in core therapeutic categories including oncology, female healthcare (including hormone replacement and oral contraceptives), cardiovascular, anti-infective and psychotherapeutics.